Fibrin sealant became the first modern era material approved as a hemostat in the United States in 1998. It is the only agent presently approved as a hemostat, sealant, and adhesive by the Food and Drug Administration (FDA). Fibrinogen is now supplied as patches in addition to the original liquid formulations. Both laboratory and clinical uses of fibrin sealant continue to grow. frequency. Fibrin sealant remains useful hemostat, sealant, and adhesive. New formulations and applications continue to be developed.. This agent remains clinically important with the recent introduction of new commercially available products. Fibrin sealant has multiple new uses that should result in further improvements in patient care.
Biopure is currently investigating the use of our technologies to use fibrinogen as a topical application in burn victims.